GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Odyssey Therapeutics, Inc. Common Stock ODTX · USD

US listing · 🇺🇸 United States

Compare

19.15

-0.42%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$3.0m

FY2022FY2025

Net income

−$148.6m

FY2022FY2025

Free cash flow

−$130.7m

FY2022FY2025

Shareholders' equity

−$488.3m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue$3.0m$4.5m$1.0m—
Gross profit$3.0m———
Research and development$126.6m$112.6m$112.3m$101.8m
Operating income−$161.2m−$135.2m−$133.4m−$122.8m
Net income−$148.6m−$129.3m−$125.9m−$124.7m
Diluted earnings per share-5.39-2.74-2.67-2.64

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets$269.8m$197.4m$286.5m$317.1m
Cash and short-term investments$181.4m———
Total liabilities$758.1m$580.0m$549.2m$461.8m
Debt$5.2m——$4.8m
Shareholders' equity−$488.3m−$382.5m−$262.7m−$144.6m
Shares outstanding28m47m47m47m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations−$129.5m−$117.5m−$112.7m−$99.8m
Capital spending−$1.2m−$764,000−$5.1m−$13.0m
Free cash flow−$130.7m−$118.2m−$117.8m−$112.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Jun 2025Mar 2025Dec 2024
Revenue——$959,000$1.9m$1.8m
Operating income−$46.7m−$39.8m−$42.5m−$44.8m−$37.1m
Net income−$52.8m−$38.3m−$41.2m−$38.4m−$35.9m
Diluted earnings per share-1.10-0.80-1.50-1.39-0.76
Cash from operations−$34.0m−$41.0m−$34.0m−$38.0m−$34.0m
Total assets$483.9m$229.1m——$197.4m
Cash and short-term investments—$175.7m———
Debt—$5.4m———
Shareholders' equity$421.2m−$523.7m——−$382.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income9.5%——
Net income6.0%——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.